secwatch.observer — SEC 8-K summary
======================================

Issuer:     Indaptus Therapeutics, Inc. (INDP)
CIK:        0001857044
Form:       8-K
Filed at:   2025-07-01T23:59:59+00:00
Accession:  0001641172-25-017283
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Indaptus raises additional $3.4M via convertible notes and warrants, total $5.7M
--------------------------------------------------------------------------------

- Second closing of private placement adds $3.4M in convertible notes; aggregate gross proceeds now $5.7M.
- Notes bear 6% interest, mature July 28, 2026; convert at 80% of 5-day VWAP (max $11.20).
- Warrants for 200% of conversion shares, 5-year term, exercise price equal to the conversion price.
- Net proceeds to fund Phase 1b/2 clinical trial, R&D, and working capital.
- Paulson Investment Company served as exclusive placement agent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1857044/000164117225017283/0001641172-25-017283-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1857044/000164117225017283/form8k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-017283

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer